ASCO 2016: Phase I Trial Results With Vorinostat in Head and Neck CancerByTheodoros Teknos, MDJune 20th 2016In this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.